Manganese-enhanced Magnetic Resonance Imaging in Takotsubo Cardiomyopathy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Manganese-enhanced Magnetic Resonance Imaging in Takotsubo Cardiomyopathy — Stella

Recruiting

Back to Takotsubo Cardiomyopathy trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United Kingdom

University of Edinburgh, Edinburgh

Key details

Sponsor

University of Edinburgh

Enrollment target

~100 participants

Started

August 2025

Primary completion

August 2028

Age range

18 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov